Clustering data with hclust algorithm for Plasma metabolomics: Comparison of non-diabetic controls with T1D patients (Study ST000045)
MS negative ion mode/C18 (Analysis AN000074)Metabolite | Structure | F1 | F2 |
---|---|---|---|
sebacicacid | ME648260 | 1.00 | NA |
beta-D-Fucose | ME648254 | 0.43 | 1.11 |
Pyroglutamicacid | ME648259 | 0.94 | 1.11 |
2-Oxo-3-hydroxy-4-phosphobutanoate | ME648248 | 0.92 | 1.17 |
Histidine | ME648256 | 0.91 | 1.18 |
2-Methoxyestrone3-glucuronide | ME648247 | 1.10 | 0.80 |
Leucine | ME648257 | 1.10 | 0.80 |
2-Butanone,4-[6-(sulfooxy)-2-naphthalenyl]- | ME648246 | 1.01 | 0.97 |
2-oxoisocaproicacid | ME648249 | 1.07 | 0.86 |
5-Aminopentanoicacid | ME648250 | 1.03 | 0.93 |
Leucine-2.2727776 | ME648258 | 1.05 | 0.90 |
Uricacid | ME648261 | 1.05 | 0.90 |
a-hydroxybutyrate | ME648253 | 1.45 | 0.35 |
Acetoaceticacid | ME648252 | 1.20 | 0.60 |
5-Aminopentanoicacid-1.419143 | ME648251 | 1.13 | 0.52 |
Dihydroxyacetone(glycerone) | ME648255 | 1.13 | 0.59 |
Factors:
F1 | Treatment:Insulin Withdrawal |
F2 | Treatment:Saline Infusion |